O2 Investment Partners announces appointment of Andrew Faubel

February 2022

Bloomfield Hills, Michigan

O2 Investment Partners (www.o2investment.com) is excited to announce the appointment of Andrew Faubel as the firm’s newest Jr. Vice President. Luke Plumpton announced the addition, “We are thrilled to have Andrew join O2. He is a strong addition to the team and we look forward to his contributions as we continue to drive portfolio growth and new deals.” 

Andrew will be responsible for sourcing and executing new transactions, due diligence, underwriting, and working in partnership with O2’s portfolio company management teams. 

Prior to joining O2, Andrew was with Crescent Cove, a TMT focused multi-strategy investment firm based in San Francisco. Prior to that, Andrew was with Evercore in New York and San Francisco, advising corporate clients on M&A and capital markets transactions. He began his career at Bank of America in New York, advising institutional and ultra high net worth clients on investment strategy. Andrew received an MBA from Columbia Business School, a BS in Management and Psychology from Boston College, and holds the Chartered Financial Analyst designation. 

About O2 Investment Partners 

O2 Investment Partners is a Midwest-based private equity firm that seeks to acquire majority interests in lower middle market B2B services, technology, and select niche industrial companies. The Firm invests in businesses with earnings growth potential and a clear path to the creation of shareholder value. Additional information is available at www.o2investment.com. 


Luke K. Plumpton 

O2 Investment Partners, LLC 



Most Recent Articles

Frontier Dental Lab Group Partners with D&S Dental Laboratory

Frontier Dental Lab Group Partners with D&S Dental Laboratory August 2022  El Dorado Hills, CA Frontier Dental Lab Group (“Frontier” or “FDL Group”) (www.frontierdentallabgroup.com), a leading dental laboratory platform, announced today that it has partnered with and made an investment in D&S Dental Laboratory, Inc. (“D&S”) (https://dnsdental.com/), a full-service dental laboratory based in Waunakee, WI. Brent West, President

Read More

BerlinRosen Expands DEI Capabilities with Investment in Onward

O2 Investment Partners (www.o2investment.com) is pleased to announce that through BerlinRosen, it has made an investment in and partnered with Onward (www.thisisonward.com) and its Managing Director, Thaly Germain, to grow its impact and create practice areas that complement BerlinRosen’s service offerings. Terms of the investment were not disclosed. O2 made a significant investment in BerlinRosen in January 2022.

Read More